Presentation: Breakthrough technology in emerging markets

Email address:

First name:

Last name:

Job title:

Company name:

Country:

I work for

Please specify your industry *

please check before submitting

Mobile number:

What is your role?

Unfortunately the document is not available at this current time, however if you leave your details we'll get it to you as soon as we can.

Please fill in all the information requested. It is very important you enter this information correctly so we can contact you with the document.

Privacy statement »

Manage your email preferences »

Remember my details Information

Remember my details

We place a 'cookie' on your computer so next time you visit us you don't need to fill in all these details

close »

Dr Jerry Sadoff, Chief Medical Officer at Crucell, joined us at the World Vaccine Congress 2012 in Washington back in April to discuss the potential growth benefits of implementing breakthrough technologies in emerging markets.

Breakthrough technology could be very beneficial to emerging markets. For example, in the application of high density, low volume cell fermentation with or without disposables combined with advanced downstream purification; in the production of classical vaccine or new combinations for emerging markets taking advantage of lower cost goods with breakthrough technologies; or in the development of new vaccines to prevent diseases where there are no current vaccines: such as Malaria, HIV and TB.

Why not download the full presentation and discover more about how breakthrough technology can serve the emerging markets?

• Using breakthrough technology to allow for lower costs of goods reaching the emerging markets
• Can the vaccine industry remain at the forefront of innovation and keep prices at a global competitive level at the same time?

Presentation: Breakthrough technology in emerging markets

information we require

please check before submitting